AGEN EURO CAN BE FUN FOR ANYONE

Emily Bodnar’s rating is predicated around the anticipation of important milestones for Agenus in the approaching calendar year, particularly the potential submitting of the Biologics License Software (BLA) for his or her guide drug prospect, botensilimab (bot). Agenus has dosed around 900 patients with bot throughout various solid tumors, showin